Related Experiment Video
Updated: Sep 7, 2025

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
Published on: April 19, 2017
Red cell distribution width, a predictive factor in immunocompromised patients with COVID-19: A comparison
Minoosh Moghimi1, Manijeh Jozpanahi2, Kasra Khodadadi3
1Department of Internal Medicine, Zanjan University of Medical Sciences, Zanjan. mmoghimi2000@yahoo.com.
Insights
Lactate dehydrogenase (LDH) was the sole predictor of death in COVID-19 patients. Active cancer patients showed higher red cell distribution width (RDW), indicating more severe disease.
Area of Science:
- Oncology
- Nephrology
- Infectious Diseases
Background:
- COVID-19 presents unique challenges for immunocompromised patients, including those with cancer or kidney transplants.
- Understanding disease outcomes in these vulnerable populations is crucial for effective management.
Purpose of the Study:
- To compare COVID-19 outcomes in cancer and kidney transplant patients.
- To identify predictors of mortality and ICU admission in these cohorts.
Main Methods:
- Single-center, historical cohort study of 1135 COVID-19 patients.
- Patients with cancer (active and non-active) and kidney transplants were analyzed.
- Disease outcomes, including mortality and ICU admission, were compared between subgroups.
Main Results:
- Lactate dehydrogenase (LDH) was the only significant predictor of death.
- Red cell distribution width (RDW) was significantly higher in active cancer patients compared to kidney transplant patients.
- Female sex and low oxygen saturation (SpO2) increased the likelihood of ICU admission.
- No significant difference in mortality was observed between active and non-active cancer groups.
Conclusions:
- Active cancer patients generally experience more severe and complicated COVID-19.
- RDW may serve as a potential predictive marker for disease severity in cancer patients with COVID-19.
- LDH is a key prognostic indicator for mortality in this patient population.
Abstract:
We aimed to review the records of cancer and kidney transplant patients of out of 1135 COVID-19 patients, who were referred to our hospital (Valiasr) in Zanjan, from March 16th, 2020, to June 11th, 2020. This was single-center, historical cohort study. Patients were divided into different subgroups and compared of disease outcomes. The only predictor of death was lactate dehydrogenase (LDH). The rate of red cell distribution width (RDW) in patients with active cancer was higher than kidney transplant patients and was statistically significant. There was no statistically significant difference in mortality between active and non-active cancer groups. Female sex and low SpO2 has increased the chances of ICU admission. Patients with active cancer generally have severe and more complicated disease and RDW can be a predictable option.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant III: Nursing Management

